Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) has been assigned an average rating of "Hold" from the seven research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $3.50.
Separately, Lake Street Capital lowered their price target on Cardlytics from $3.00 to $2.50 and set a "hold" rating on the stock in a report on Thursday, May 8th.
Check Out Our Latest Analysis on CDLX
Cardlytics Price Performance
Shares of NASDAQ:CDLX traded down $0.25 on Thursday, hitting $2.45. The company's stock had a trading volume of 1,384,642 shares, compared to its average volume of 2,138,374. The company has a 50-day simple moving average of $1.86 and a 200 day simple moving average of $2.20. Cardlytics has a 1 year low of $1.22 and a 1 year high of $8.94. The company has a market capitalization of $128.63 million, a PE ratio of -0.69 and a beta of 1.21. The company has a debt-to-equity ratio of 2.62, a current ratio of 1.19 and a quick ratio of 1.19.
Hedge Funds Weigh In On Cardlytics
A number of large investors have recently modified their holdings of CDLX. Post Resch Tallon Group Inc. raised its holdings in shares of Cardlytics by 100.0% during the 2nd quarter. Post Resch Tallon Group Inc. now owns 20,000 shares of the company's stock valued at $33,000 after buying an additional 10,000 shares in the last quarter. Jump Financial LLC purchased a new position in Cardlytics in the 1st quarter worth approximately $41,000. ProShare Advisors LLC purchased a new position in Cardlytics in the 4th quarter worth approximately $43,000. Virtu Financial LLC purchased a new position in Cardlytics in the 4th quarter worth approximately $62,000. Finally, Intech Investment Management LLC grew its position in shares of Cardlytics by 31.3% in the 4th quarter. Intech Investment Management LLC now owns 19,310 shares of the company's stock worth $72,000 after buying an additional 4,607 shares during the last quarter. 68.10% of the stock is owned by hedge funds and other institutional investors.
About Cardlytics
(
Get Free ReportCardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
See Also
Before you consider Cardlytics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardlytics wasn't on the list.
While Cardlytics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
